Deutsche Bank cautious on Cognizant, says growth thesis hasn’t played out
📉 Deutsche Bank downgraded Cognizant Technology Solutions (CTSH) from Buy to Hold with a price target cut to $66.
📊 Analyst Nate Svensson stated that the growth thesis focusing on large deals and vendor consolidation has not played out as expected.
📅 Organic revenue growth is now projected to exit 2026 at roughly 2% year over year with limited catalysts for improvement in 2027.
⚠️ Key drivers for a weaker fourth-quarter outlook include softer demand in health sciences and consumer-facing client segments.
🤖 While AI execution and large-deal positioning remain strengths, they are deemed insufficient to drive broad growth previously expected.
📉 The stock is no longer considered deserving of trading multiples comparable to competitor Accenture (ACN).
🚀 Cognizant shares have rallied approximately 67% from the June 30 low despite deteriorating fundamentals.
💭 Deutsche Bank attributes the recent rally primarily to a momentum unwind and overly draconian valuation metrics rather than business improvement.
- Cognizant maintains strong positioning in large deals and demonstrates effective AI execution capabilities.
- The company's strategy of consolidating clients' vendors was previously viewed as a key driver for sustaining above-industry growth.
- Deutsche Bank downgraded the stock to Hold citing less confidence in the ability to improve organic revenue growth in the near term.
- Analysts now see a longer path to faster growth, projecting organic expansion to exit 2026 at only about 2% year over year.
- Softer demand in health sciences and among consumer-facing clients is driving a weaker fourth-quarter outlook that appears to extend beyond the current quarter.
- The stock has rallied 67% from its June 30 low while fundamentals have deteriorated, suggesting the price move may be disconnected from operational reality.